Når der skal tages stilling til om behandling med APTIVUS med lavdosis ritonavir skal initieres, skal forhistorien for den enkelte patient nøje evalueres samt mønstrene for mutationer ved forskellige lægemidler.
In deciding to initiate treatment with APTIVUS, co-administered with low dose ritonavir, careful consideration should be given to the treatment history of the individual patient and the patterns of mutations associated with different agents.